Hyperammonemia

Approved for this indication (5)

• carglumic acid
• phenylacetic acid
• sodium phenylbutyrate
• sodium benzoate
• benzyl benzoate

Phase 2 trials (1)

• tnp-2092

Phase 1 trials (1)

• pbi-4050

Organization Involved with Phase 3 Indications (3)

• National Institutes of Health (NIH)
• Children's National Research Institute
• Children's National Medical Center

Organization Involved with Phase 2 Indications (9)

• Ocera Therapeutics
• University of Pennsylvania
• University of Pittsburgh
• Case Western Reserve University
• Harvard University
• Stanford University
• University of California, Los Angeles
• Icahn School of Medicine at Mount Sinai
• University of Colorado

Organization Involved with Phase 1 Indications (2)

• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• University of Utah

Organization Involved with Other Experimental Indications (1)

• Institute of Liver and Biliary Sciences, India